<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27025584</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-9957</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2016</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Infectious diseases of poverty</Title><ISOAbbreviation>Infect Dis Poverty</ISOAbbreviation></Journal><ArticleTitle>Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.</ArticleTitle><Pagination><StartPage>27</StartPage><MedlinePgn>27</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">27</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40249-016-0124-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand, foot, and mouth disease (HFMD) caused by enterovirus 71 (EV71) is a potentially life-threatening infectious disease that commonly occurs in children. Diagnosis of HFMD caused by EV71 largely depends on clinical manifestations and rare serological biomarkers used to identify children suffering from HFMD. Serum cholinesterase (SChE) activity has frequently been reported as a potential biomarker for solid central nervous system tumors, chronic heart failure, and liver cirrhosis. However, its potential value in the diagnosis of neurotropic virus infections, such as HFMD caused by EV71, remains to be determined.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">In our study, 220 children hospitalized with HFMD caused by EV71, 34 inpatients infected with coxsackievirus A16 (CVA16), and 43 undefined enterovirus-infected HFMD inpatients were recruited at the Anhui Provincial Children's Hospital between January 2011 and December 2012. SChE activity was measured. The non-parametric Mann-Whitney U test showed that SChE activity in children diagnosed with HFMD caused by EV71 was significantly higher than in healthy controls (p&#x2009;&lt;&#x2009;0.001), as well as in children with upper respiratory tract infections (p&#x2009;=&#x2009;0.011), bronchopneumonia (p&#x2009;&lt;&#x2009;0.001), septicemia (p&#x2009;&lt;&#x2009;0.001), amygdalitis (p&#x2009;&lt;&#x2009;0.001), and appendicitis (p&#x2009;&lt;&#x2009;0.001). In addition, higher SChE activity was observed in male inpatients with HFMD caused by EV71 (47.7 % positivity) compared to female inpatients (26.1 % positivity) (chi-square test, p&#x2009;=&#x2009;0.002). In our study, no significant differences in SChE levels were observed among different ages (up to 120 months) (r&#x2009;=&#x2009;-0.112, p&#x2009;&gt;&#x2009;0.05). An important finding was that SChE activity declined in the recovery phase of HFMD caused by EV71 compared to the acute phase (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Elevated SChE activity was observed in patients with severe HFMD caused by EV71. Therefore, SChE might be a potential assistant biomarker for the diagnosis of HFMD caused by EV71 in children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Bang-Ning</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Anhui Provincial Children's Hospital, Hefei, 230051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Yu-Lian</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Anhui Provincial Children's Hospital, Hefei, 230051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Bi-Quan</ForeName><Initials>BQ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Anhui Provincial Children's Hospital, Hefei, 230051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Li-Yan</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zi-Cheng</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Anhui Provincial Children's Hospital, Hefei, 230051, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Anhui Provincial Children's Hospital, Hefei, 230051, China. taoshen@hsc.pku.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, 100191, China. taoshen@hsc.pku.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis Poverty</MedlineTA><NlmUniqueID>101606645</NlmUniqueID><ISSNLinking>2049-9957</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.8</RegistryNumber><NameOfSubstance UI="D002802">Cholinesterases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002802" MajorTopicYN="N">Cholinesterases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biochemical marker</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Coxsackievirus A16</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">Serum cholinesterase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27025584</ArticleId><ArticleId IdType="pmc">PMC4812613</ArticleId><ArticleId IdType="doi">10.1186/s40249-016-0124-y</ArticleId><ArticleId IdType="pii">10.1186/s40249-016-0124-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Offical report of the National health and Family Planning Commission of China. http://www.nhfpc.gov.cn/jkj/s3578/201402/26700e8a83c04205913a106545069a11.shtml. Accessed 13 Feb 2014.</Citation></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;90. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Xu G, Dong H, Ye M, He T. A case-control study of risk factors for severe hand-foot-mouth disease among children in Ningbo, China, 2010&#x2013;2011. Eur J Pediatr. 2012;171(9):1359&#x2013;64. doi: 10.1007/s00431-012-1731-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-012-1731-7</ArticleId><ArticleId IdType="pubmed">22527564</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936&#x2013;42. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354(9191):1682&#x2013;6. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Teng G, Tong H, Jiao Y, Zhang T, Chen H, et al. Study on risk factors for severe hand, foot and mouth disease in China. PLoS ONE. 2014;9(1):e87603. doi: 10.1371/journal.pone.0087603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087603</ArticleId><ArticleId IdType="pmc">PMC3906182</ArticleId><ArticleId IdType="pubmed">24489943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R, Xu L, Zhang N, Zhu K, Yang J, Yang C, et al. Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease. Virus Res. 2013;177(1):62&#x2013;5. doi: 10.1016/j.virusres.2013.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.07.009</ArticleId><ArticleId IdType="pubmed">23886670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chougule A, Hussain S, Agarwal DP. Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy. J Cancer Res Ther. 2008;4(1):21&#x2013;5. doi: 10.4103/0973-1482.39601.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-1482.39601</ArticleId><ArticleId IdType="pubmed">18417898</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva CB, Wolkmer P, Da Silva AS, Paim FC, Tonin AA, Castro VS, et al. Cholinesterases as markers of the inflammatory process in rats infected with Leptospira interrogans serovar Icterohaemorrhagiae. J Med Microbiol. 2012;61(Pt 2):278&#x2013;84. doi: 10.1099/jmm.0.035501-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.035501-0</ArticleId><ArticleId IdType="pubmed">21921108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health of the People&#x2019;s Republic of China Diagnosis and treatment guideline on hand-foot-mouth disease. Int J Res Mark. 2010;30(24):1473&#x2013;5.</Citation></Reference><Reference><Citation>He SJ, Han JF, Ding XX, Wang YD, Qin CF. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010. Int J Infect Dis. 2013;17(11):e1025&#x2013;30. doi: 10.1016/j.ijid.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2013.04.003</ArticleId><ArticleId IdType="pubmed">23791223</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308&#x2013;18. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Luo L, Yan S, Wen T, Bai W, Li H, et al. Clinical Features for Mild Hand, Foot and Mouth Disease in China. PLoS ONE. 2015;10(8):e0135503. doi: 10.1371/journal.pone.0135503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135503</ArticleId><ArticleId IdType="pmc">PMC4547800</ArticleId><ArticleId IdType="pubmed">26302092</ArticleId></ArticleIdList></Reference><Reference><Citation>La Du BN, Lockridge O. Molecular biology of human serum cholinesterase. Fed Proc. 1986;45(13):2965&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3536596</ArticleId></ArticleIdList></Reference><Reference><Citation>Silman I, Sussman JL. Acetylcholinesterase: &#x2018;classical&#x2019; and &#x2018;non-classical&#x2019; functions and pharmacology. Curr Opin Pharmacol. 2005;5(3):293&#x2013;302. doi: 10.1016/j.coph.2005.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2005.01.014</ArticleId><ArticleId IdType="pubmed">15907917</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarpia L, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachex Sarcopenia Muscle. 2013;4(1):31&#x2013;9. doi: 10.1007/s13539-012-0083-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13539-012-0083-5</ArticleId><ArticleId IdType="pmc">PMC3581611</ArticleId><ArticleId IdType="pubmed">22956442</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikecin L, Krizmaric M, Stepan Giljevic J, Gjurasin M, Kern J, Lenicek Krleza J, et al. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children. Croat Med J. 2013;54(5):429&#x2013;35. doi: 10.3325/cmj.2013.54.429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2013.54.429</ArticleId><ArticleId IdType="pmc">PMC3816568</ArticleId><ArticleId IdType="pubmed">24170721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Yamauchi H, Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, et al. Serum cholinesterase is an important prognostic factor in chronic heart failure. Heart Vessels. 2015; 30(2): 204-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">24463844</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F, Yin X, Ma X, Guo XD, Jin B, Li H. Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomed Rep. 2013;1(2):265&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3917072</ArticleId><ArticleId IdType="pubmed">24648933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran J, Sajith KG, Priya S, Dutta AK, Balasubramanian KA. Serum cholinesterase is an excellent biomarker of liver cirrhosis. Trop Gastroenterol. 2014;35(1):15&#x2013;20. doi: 10.7869/tg.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.7869/tg.158</ArticleId><ArticleId IdType="pubmed">25276901</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenhar-Tsarfaty S, Berliner S, Bornstein NM, Soreq H. Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci. 2014;53(3):298&#x2013;305. doi: 10.1007/s12031-013-0176-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-013-0176-4</ArticleId><ArticleId IdType="pubmed">24254221</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>